WIM
ENZ

Wittenberg Investment Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Wittenberg Investment Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-274,095
Closed -$101K – 80
2025
Q1 		$101K Buy
274,095
+86,558
+46% +$47.8K 0.05% 72
2024
Q4 		$134K Buy
187,537
+70,400
+60% +$73K 0.05% 71
2024
Q3 		$131K Hold
117,137
– – 0.04% 78
2024
Q2 		$128K Buy
117,137
+49,134
+72% +$55.3K 0.04% 78
2024
Q1 		$86.4K Hold
68,003
– – 0.03% 80
2023
Q4 		$94.5K Buy
+68,003
New +$90.2K 0.03% 77

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Wittenberg Investment Management's ENZ Position: Q2 2025 in Review

Wittenberg Investment Management sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 274,095 shares — an estimated $101K sold.

Wittenberg Investment Management first reported a position in ENZ in Q4 2023 and held it in 6 quarters. The position peaked at $134K in Q4 2024. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Wittenberg Investment Management reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Wittenberg Investment Management sold 274,095 Enzo Biochem, Inc. shares in Q2 2025, an estimated $101K.
  • Wittenberg Investment Management first reported a position in Enzo Biochem, Inc. in Q4 2023 and held it in 6 quarters.
  • Wittenberg Investment Management's Enzo Biochem, Inc. position peaked at $134K in Q4 2024.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Wittenberg Investment Management's 13F filing for Q2 2025, filed 11 Aug 2025.